Analysen von James Gordon
| 05.05.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.04.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.04.20 | GSK Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 19.03.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 10.03.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.02.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.02.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.02.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.01.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 13.01.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 17.12.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.12.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 19.11.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 11.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.10.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 30.10.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 29.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.10.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.10.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 14.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.09.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.09.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.09.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.08.19 | Alcon Neutral | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.08.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.08.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 07.08.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |